Exploring and exploiting the aberrant DNA methylation profile of endocrine-resistant breast cancer-Reference-Cited by-同舟云学术

Exploring and exploiting the aberrant DNA methylation profile of endocrine-resistant breast cancer

Published:2013-12 Issue:6 Volume:5 Page:595-598
ISSN:1750-1911
Container-title:Epigenomics
language:en
Short-container-title:Epigenomics

Author:

Stone Andrew¹,Valdes-Mora Fatima²,Clark Susan J²

Affiliation:

1. Cancer Epigenetics Program, Garvan Institute of Medical Research, Sydney, NSW, Australia.

2. Cancer Epigenetics Program, Garvan Institute of Medical Research, Sydney, NSW, Australia and St Vincent’s Clinical School, Faculty of Medicine, UNSW, St Vincent’s Hospital, Sydney, NSW, Australia

Publisher

Future Medicine Ltd

Subject

Cancer Research,Genetics

Link

https://www.futuremedicine.com/doi/pdf/10.2217/epi.13.70

Reference31 articles.

1. Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer

2. Biological determinants of endocrine resistance in breast cancer

3. Breast Cancer Adjuvant Therapy: Time to Consider Its Time-Dependent Effects

4. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

5. Metastatic Behavior of Breast Cancer Subtypes

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genistein induces endocrine resistance in human breast cancer by suppressing H3K27 trimethylation;Endocrine-Related Cancer;2023-02-01

2. Targeting cancer epigenetic pathways with small-molecule compounds: Therapeutic efficacy and combination therapies;Pharmacological Research;2021-11

3. Dysregulation of DNA methylation patterns may identify patients with breast cancer resistant to endocrine therapy: A predictive classifier based on differentially methylated regions;Oncology Letters;2019-05-27

4. Endocrine Therapy of Estrogen Receptor-Positive Breast Cancer Cells: Early Differential Effects on Stem Cell Markers;Frontiers in Oncology;2017-09-04

5. Minireview: Therapeutic Implications of Epigenetic Signaling in Breast Cancer;Endocrinology;2016-12-16